{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T17:32:36Z","timestamp":1762623156244},"reference-count":65,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.lpm.2008.03.011","type":"journal-article","created":{"date-parts":[[2008,6,14]],"date-time":"2008-06-14T09:08:56Z","timestamp":1213434536000},"page":"1591-1598","source":"Crossref","is-referenced-by-count":1,"title":["Prise en charge de la r\u00e9activation virale B au cours d\u2019un traitement chimioth\u00e9rapique ou immunosuppresseur"],"prefix":"10.1016","volume":"37","author":[{"given":"Ali","family":"Amouri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lassaad","family":"Chtourou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila","family":"Mnif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabi","family":"Tahri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2008.03.011_bib1","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0016-5085(91)90599-G","article-title":"Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study","volume":"100","author":"Lok","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lpm.2008.03.011_bib2","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1136\/gut.2005.070763","article-title":"Hepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapy","volume":"54","author":"Hui","year":"2005","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.lpm.2008.03.011_bib3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.gastro.2006.04.015","article-title":"Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy","volume":"131","author":"Hui","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lpm.2008.03.011_bib4","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1053\/j.gastro.2003.09.026","article-title":"Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy","volume":"125","author":"Lau","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lpm.2008.03.011_bib5","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.cgh.2006.03.017","article-title":"Chronic heapatitis B: current testing strategies","volume":"4","author":"Gish","year":"2006","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/j.lpm.2008.03.011_bib6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1600-0676.1990.tb00449.x","article-title":"Spontaneous reactivation of hepatitis B virus infection in patients with chronic type B hepatitis","volume":"10","author":"Fattovich","year":"1990","journal-title":"Liver"},{"key":"10.1016\/j.lpm.2008.03.011_bib7","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/0016-5085(84)90406-2","article-title":"Spontaneous reactivation of chronic hepatitis B virus infection","volume":"86","author":"Davis","year":"1984","journal-title":"Gastroenterology"},{"issue":"5 Pt 1","key":"10.1016\/j.lpm.2008.03.011_bib8","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/0016-5085(91)70034-U","article-title":"Redevelopment of hepatitis B surface antigen after renal transplantation","volume":"100","author":"Marcellin","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lpm.2008.03.011_bib9","doi-asserted-by":"crossref","first-page":"447","DOI":"10.7326\/0003-4819-96-4-447","article-title":"Reactivation of chronic hepatitis B virus infection by cancer chemotherapy","volume":"96","author":"Hoofnagle","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2008.03.011_bib10","first-page":"911","article-title":"Fatal reactivation of chronic hepatitis B virus infection following withdrawal of chemotherapy in lymphoma patients","volume":"73","author":"Lau","year":"1989","journal-title":"Q J Med"},{"key":"10.1016\/j.lpm.2008.03.011_bib11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/sj.bmt.1702093","article-title":"Fulminant hepatitis B following bone marrow transplantation in an HBsAg-negative, HBsAb-positive recipient; reactivation of dormant virus during the immunosuppressive period","volume":"25","author":"Iwai","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.lpm.2008.03.011_bib12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/sj.bmt.1700885","article-title":"Hepatitis B virus infection in allogeneic bone marrow transplantation","volume":"20","author":"Ustun","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.lpm.2008.03.011_bib13","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/hep.1840030309","article-title":"Natural history of hepatitis B virus infection in renal transplant recipients \u2014 a fifteen-year follow-up","volume":"3","author":"Dusheiko","year":"1983","journal-title":"Hepatology"},{"key":"10.1016\/j.lpm.2008.03.011_bib14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00000658-200101000-00020","article-title":"Reactivation of viral replication after liver resection in patients infected with hepatitis B virus","volume":"233","author":"Kubo","year":"2001","journal-title":"Ann Surg"},{"key":"10.1016\/j.lpm.2008.03.011_bib15","first-page":"2925","article-title":"Reactivation of hepatitis B but not hepatitis C in patients with malignant lymphoma and immunosuppressive therapy. A prospective study in 305 patients","volume":"46","author":"Markovic","year":"1999","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.lpm.2008.03.011_bib16","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1478-3231.2004.0964.x","article-title":"Hepatitis B virus reactivation in breast cancer patients undergoing cytotoxic chemotherapy and the role of preemptive lamivudine administration","volume":"24","author":"Dai","year":"2004","journal-title":"Liver Int"},{"key":"10.1016\/j.lpm.2008.03.011_bib17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.21051","article-title":"Diagnosis prevention and management of hepatitis B virus reactivation during anticancer therapy","volume":"43","author":"Yeo","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.lpm.2008.03.011_bib18","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1053\/jhep.2003.50220","article-title":"Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma","volume":"37","author":"Cheng","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.lpm.2008.03.011_bib19","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1073\/pnas.83.6.1627","article-title":"Hepatitis B virus DNA contains a glucocorticoid-responsive element","volume":"83","author":"Tur-Kaspa","year":"1986","journal-title":"Proceedings of the National Academy of Science, USA"},{"key":"10.1016\/j.lpm.2008.03.011_bib20","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/0042-6822(88)90127-4","article-title":"The glucocorticoid receptor recognizes a specific nucleotide sequence in hepatitis B virus DNA causing increased activity of the HBV enhancer","volume":"167","author":"Tur-Kaspa","year":"1988","journal-title":"Virology"},{"key":"10.1016\/j.lpm.2008.03.011_bib21","first-page":"3035","article-title":"Doxorubicin activates hepatitis B virus (HBV) replication in HBV-harboring hepatoblastoma cells. A possible novel mechanism of HBV reactivation in HBV carriers receiving systemic chemotherapy","volume":"24","author":"Hsu","year":"2004","journal-title":"Anticancer Res"},{"key":"10.1016\/j.lpm.2008.03.011_bib22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/1096-9071(200011)62:3<299::AID-JMV1>3.0.CO;2-0","article-title":"Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors","volume":"62","author":"Yeo","year":"2000","journal-title":"J Med Virol"},{"issue":"Suppl 1","key":"10.1016\/j.lpm.2008.03.011_bib23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1023\/A:1008234807768","article-title":"Hepatitis B virus carriers in the treatment of malignant lymphoma: an epidemiological study in Japan","volume":"8","author":"Kumagai","year":"1997","journal-title":"Ann Oncol"},{"issue":"12","key":"10.1016\/j.lpm.2008.03.011_bib24","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0399-8320(06)73575-8","article-title":"Reactivation of hepatitis B after cessation of Rituximab monotherapy","volume":"30","author":"Nancey","year":"2006","journal-title":"Gastroenterol Clin Biol"},{"issue":"3","key":"10.1016\/j.lpm.2008.03.011_bib25","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1600-0609.2004.00375.x","article-title":"Hepatitis B virus reactivation and alemtuzumab therapy","volume":"74","author":"Iannitto","year":"2005","journal-title":"Eur J Haematol"},{"issue":"9","key":"10.1016\/j.lpm.2008.03.011_bib26","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/gut.2004.040675","article-title":"Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis","volume":"53","author":"Esteve","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.lpm.2008.03.011_bib27","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/00007890-199810150-00012","article-title":"Reactivation of hepatitis B after transplantation in patients with pre-existing anti-hepatitis B surface antigen antibodies: report on three cases and review of the literature","volume":"66","author":"Blanpain","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.lpm.2008.03.011_bib28","first-page":"770","article-title":"R\u00e9activation virale B apr\u00e8s greffe de moelle allog\u00e9nique chez un malade pr\u00e9c\u00e9demment gu\u00e9ri d\u2019une h\u00e9patite virale B","volume":"23","author":"Romand","year":"1999","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.lpm.2008.03.011_bib29","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/01.TP.0000163468.80223.74","article-title":"Solid-organ transplantation in HBsAg-negative patients with antibodies to HBV core antigen: low risk of HBV reactivation","volume":"79","author":"Kn\u00f6ll","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.lpm.2008.03.011_bib30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1046\/j.1352-0504.2003.00467.x","article-title":"High hepatitis B virus (HBV) DNA viral load is an important risk factor for HBV reactivation in breast cancer patients undergoing cytotoxic chemotherapy","volume":"11","author":"Zhong","year":"2004","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.lpm.2008.03.011_bib31","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1093\/annonc\/mdh430","article-title":"Hepatitis B reactivation in patients with hepatocellular carcinoma undergoing systemic chemotherapy","volume":"15","author":"Yeo","year":"2004","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.lpm.2008.03.011_bib32","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1182\/blood-2004-09-3402","article-title":"Clinical significance of intrahepatic hepatitis B virus covalently closed circular DNA in chronic hepatitis B patients who received cytotoxic chemotherapy","volume":"105","author":"Hui","year":"2005","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.lpm.2008.03.011_bib33","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1046\/j.1365-2893.2000.00257.x","article-title":"Sequence variations of precore\/core and precore promoter regions of hepatitis B virus in patients with or without viral reactivation during cytotoxic chemotherapy","volume":"7","author":"Yeo","year":"2000","journal-title":"J Viral Hepat"},{"issue":"9","key":"10.1016\/j.lpm.2008.03.011_bib34","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1365-2893.2006.00728.x","article-title":"Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations","volume":"13","author":"Alexopoulou","year":"2006","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.lpm.2008.03.011_bib35","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S0140-6736(71)91715-6","article-title":"Frequency of Australia antigen in patients with leukaemia in different countries","volume":"1","author":"Sutnick","year":"1971","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2008.03.011_bib36","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1200\/JCO.1999.17.1.394","article-title":"Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers: a review of the problem","volume":"17","author":"Liang","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lpm.2008.03.011_bib37","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1002\/(SICI)1097-0142(19961115)78:10<2210::AID-CNCR24>3.0.CO;2-0","article-title":"Severe hepatitis related to chemotherapy in hepatitis B virus carriers with hematologic malignancies. Survey in Japan, 1987\u20131991","volume":"78","author":"Nakamura","year":"1996","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.lpm.2008.03.011_bib38","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/hep.21513","article-title":"Chronic hepatitis B","volume":"45","author":"Lok","year":"2007","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.lpm.2008.03.011_bib39","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1478-3231.2005.01134.x","article-title":"Asian-Pacific consensus update working party on chronic hepatitis B. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update","volume":"25","author":"Liaw","year":"2005","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.lpm.2008.03.011_bib40","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1542-3565(03)00312-4","article-title":"A treatment algorithm for the management of chronic hepatitis B virus infection in the United States","volume":"2","author":"Keeffe","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.lpm.2008.03.011_bib41","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1365-2141.2006.06465.x","article-title":"Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies","volume":"136","author":"Lalazar","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.lpm.2008.03.011_bib42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.idc.2006.01.004","article-title":"Hepatitis B vaccines","volume":"20","author":"Yu","year":"2006","journal-title":"Infectious Dis Clin North Am"},{"key":"10.1016\/j.lpm.2008.03.011_bib43","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0168-8278(03)00152-1","article-title":"Hepatitis B vaccines","volume":"39","author":"Shouval","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.lpm.2008.03.011_bib44","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/sj.bmt.1702571","article-title":"Maintenance of immune memory to hepatitis B envelope protein following adoptive transfer of immunity in bone marrow transplant recipients","volume":"26","author":"Ilan","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.lpm.2008.03.011_bib45","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/0168-8278(95)80317-3","article-title":"Transplantation of hepatitis B immune lymphocytes as means for adoptive transfer of immunity to hepatitis B virus","volume":"23","author":"Shouval","year":"1995","journal-title":"J Hepatol"},{"key":"10.1016\/j.lpm.2008.03.011_bib46","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s002770050510","article-title":"Prevention of hepatitis B flare-up during chemotherapy using lamivudine: case report and review of the literature","volume":"78","author":"Al-Taie","year":"1999","journal-title":"Ann Hematol"},{"key":"10.1016\/j.lpm.2008.03.011_bib47","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1572-0241.1999.00808.x","article-title":"Lamivudine therapy in chemotherapy-induced reactivation of hepatitis B virus infection","volume":"94","author":"Ahmed","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.lpm.2008.03.011_bib48","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1023\/A:1008206519571","article-title":"Successful treatment with lamivudine for fulminant reactivated hepatitis B infection following intensive therapy for high-grade Hodgkin's lymphoma","volume":"9","author":"Clark","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1016\/j.lpm.2008.03.011_bib49","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1093\/jac\/dkl123","article-title":"Antiviral options for the treatment of chronic hepatitis B","volume":"57","author":"Osborn","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.lpm.2008.03.011_bib50","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/sj.bmt.1701266","article-title":"Lamivudine treatment for chronic replicative hepatitis B virus infection after allogeneic bone marrow transplantation","volume":"21","author":"Picardi","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.lpm.2008.03.011_bib51","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S1470-2045(02)00773-8","article-title":"Reactivation of replication of hepatitis B and C viruses after immunosuppression therapy: an unresolved issue","volume":"3","author":"Vento","year":"2002","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.lpm.2008.03.011_bib52","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJMoa051285","article-title":"A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B","volume":"354","author":"Chang","year":"2006","journal-title":"New Engl J Med"},{"key":"10.1016\/j.lpm.2008.03.011_bib53","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa051287","article-title":"Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B","volume":"354","author":"Lai","year":"2006","journal-title":"New Engl J Med"},{"key":"10.1016\/j.lpm.2008.03.011_bib54","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1046\/j.1365-2141.2001.03099.x","article-title":"Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy","volume":"115","author":"Rossi","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.lpm.2008.03.011_bib55","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.1365-2893.2003.00479.x","article-title":"Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies","volume":"11","author":"Idilman","year":"2004","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.lpm.2008.03.011_bib56","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/01.coc.0000159554.97885.88","article-title":"Prevention of hepatitis B virus reactivation in patients with nasopharyngeal carcinoma with lamivudine","volume":"28","author":"Yeo","year":"2005","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.lpm.2008.03.011_bib57","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10549-004-0725-1","article-title":"Use of lamivudine to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patient","volume":"88","author":"Yeo","year":"2004","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.lpm.2008.03.011_bib58","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1046\/j.1365-2036.2002.01364.x","article-title":"Prophylactic lamivudine prevents hepatitis B reactivation in chemotherapy patients","volume":"16","author":"Lim","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.lpm.2008.03.011_bib59","first-page":"1320","article-title":"Lamivudine prophylaxis reduces the incidence and severity of hepatitis in hepatitis B virus carriers who receive chemotherapy for lymphoma","volume":"15","author":"Lin","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.lpm.2008.03.011_bib60","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00520-003-0549-2","article-title":"Preemptive use of lamivudine in breast cancer patients carrying hepatitis B virus undergoing cytotoxic chemotherapy: a longitudinal study","volume":"12","author":"Dai","year":"2004","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.lpm.2008.03.011_bib61","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/ajh.20471","article-title":"Prevention of hepatitis B reactivation with lamivudine in hepatitis B virus carriers with hematologic malignancies treated with chemotherapy \u2013 a prospective case series","volume":"80","author":"Vassiliadis","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1016\/j.lpm.2008.03.011_bib62","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/08880010490273019","article-title":"Lamivudine facilitates optimal chemotherapy in hepatitis B virusinfected children with haematological malignancies: a preliminary report","volume":"21","author":"el-Sayed","year":"2004","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.lpm.2008.03.011_bib63","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1182\/blood.V100.2.391","article-title":"Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers","volume":"100","author":"Shibolet","year":"2002","journal-title":"Blood"},{"issue":"Suppl. 1","key":"10.1016\/j.lpm.2008.03.011_bib64","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2893.1997.tb00171.x","article-title":"Hepatitis B virus and liver transplantation: concepts in antiviral prophylaxis","volume":"4","author":"Grellier","year":"1997","journal-title":"J Viral Hepat"},{"issue":"2","key":"10.1016\/j.lpm.2008.03.011_bib65","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/hep.21513","article-title":"AASLD Practice Guidelines: Chronic Hepatitis B","volume":"45","author":"Lok","year":"2007","journal-title":"Hepatol"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498208003266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498208003266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,12]],"date-time":"2019-05-12T03:40:20Z","timestamp":1557632420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498208003266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":65,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0755498208003266"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2008.03.011","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}